Literature DB >> 3911881

Elimination of plasmids by new 4-quinolones.

J Weisser, B Wiedemann.   

Abstract

Nalidixic acid and six of the new 4-quinolones eliminated F'lac and various native R plasmids from Escherichia coli at one half or one quarter the MIC. Four of eight plasmids tested were cured by all derivatives, with frequencies from 10 to 98%. Quinolones did not eliminate all plasmids that were cured by novobiocin, and vice versa.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3911881      PMCID： PMC176363          DOI： 10.1128/AAC.28.5.700

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

1.  THE EFFECT OF ACRIDINE DYES ON MATING TYPE FACTORS IN ESCHERICHIA COLI.

Authors:  Y Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  1960-01       Impact factor: 11.205

2.  Elimination of plasmids from several bacterial species by novobiocin.

Authors:  G L McHugh; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

3.  R factors from Proteus rettgeri.

Authors:  J N Coetzee; N Datta; R W Hedges
Journal:  J Gen Microbiol       Date:  1972-10

4.  The problems of drug-resistant pathogenic bacteria. Practical effectiveness of agents curing R factors and plasmids.

Authors:  D H Bouanchaud; Y A Chabbert
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

5.  The problems of drug-resistant pathogenic bacteria. Elimination of bacterial episomes by DNA-complexing compounds.

Authors:  F E Hahn; J Ciak
Journal:  Ann N Y Acad Sci       Date:  1971-06-11       Impact factor: 5.691

6.  The effect of R-factor plasmids on host-cell responses to nalidixic acid I. Increased susceptibility of nalidixic acid-sensitive hosts.

Authors:  G C Crumplin; J T Smith
Journal:  J Antimicrob Chemother       Date:  1981-04       Impact factor: 5.790

7.  Isolation of two strains of Klebsiella pneumoniae with transferable resistance determinants against ten antimicrobial drugs from clinical material.

Authors:  W H Traub; I Kleber
Journal:  Zentralbl Bakteriol Orig A       Date:  1974

8.  Incompatibility groups and the classification of fi - resistance factors.

Authors:  Y A Chabbert; M R Scavizzi; J L Witchitz; G R Gerbaud; D H Bouanchaud
Journal:  J Bacteriol       Date:  1972-11       Impact factor: 3.490

9.  Elimination of plasmid pMG110 from Escherichia coli by novobiocin and other inhibitors of DNA gyrase.

Authors:  D C Hooper; J S Wolfson; G L McHugh; M D Swartz; C Tung; M N Swartz
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

10.  Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA).

Authors:  U van Treeck; F Schmidt; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191
View more
  16 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.

Authors:  B L Masecar; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Mechanisms that may account for differential antibiotic susceptibilities among Coxiella burnetii isolates.

Authors:  M R Yeaman; O G Baca
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

4.  [Inhibition of gyrase by 4-quinolones: effect on the structure of DNA].

Authors:  J Weisser; B Wiedemann
Journal:  Infection       Date:  1986       Impact factor: 3.553

5.  Clinical uses of nalidixic acid analogues: the fluoroquinolones.

Authors:  N Høiby
Journal:  Eur J Clin Microbiol       Date:  1986-04       Impact factor: 3.267

6.  Inhibition of R-plasmid transfer in Escherichia coli by 4-quinolones.

Authors:  J Weisser; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

Review 7.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

8.  Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.

Authors:  J Fung-Tomc; B Kolek; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

10.  Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays.

Authors:  S W Mamber; B Kolek; K W Brookshire; D P Bonner; J Fung-Tomc
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.